BDBM286162 4-(4-(2-chloro-3- (trifluoromethyl) benzyloxy) [2.2.1]heptan- 1-yl)butanoic acid::US9518000, Example 55
SMILES: OC(=O)CCCC12CCC(CC1)(C2)OCc1cccc(c1Cl)C(F)(F)F
InChI Key: InChIKey=FVZIMOZCQASBOS-UHFFFAOYSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free fatty acid receptor 4 (Homo sapiens (Human)) | BDBM286162 (4-(4-(2-chloro-3- (trifluoromethyl) benzyloxy) [2....) | Reactome pathway KEGG GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 170 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for... | US Patent US9518000 (2016) BindingDB Entry DOI: 10.7270/Q2GH9M00 | |||||||||||
More data for this Ligand-Target Pair |